- Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market?
[作者:Albers, LJ; Musenga, A; Raggi, MA,期刊:Expert opinion on investigational drugs, 页码:61-75 , 文章类型: Article,,卷期:2008年17-1]
Iloperidone is a new-generation atypical antipsychotic agent, acting as a serotonin/dopamine (5-HT2A/D-2) antagonist, under development by Vanda Pharmaceuticals for the treatment of schizophrenia, bipolar disorder and...
|